Skip to main content
. 2025 Jan 15;17(1):98168. doi: 10.4251/wjgo.v17.i1.98168

Table 1.

Baseline characteristics of patients who underwent laparoscopic pancreaticoduodenectomy, n (%)

Variables
Total (n = 804)
Red blood cell distribution width
P value
< 15.4 (n = 573)
≥ 15.4 (n = 231)
Age, years
    < 65 478 (59.5) 353 (61.6) 125 (54.1) 0.050
    ≥ 65 326 (40.5) 220 (38.4) 106 (45.9)
Sex 0.325
    Male 529 (65.8) 383 (66.8) 146 (63.2)
    Female 275 (34.2) 190 (33.2) 85 (36.8)
Body mass index, kg/m2
    < 25 500 (62.2) 341 (59.5) 159 (68.8) 0.014
    ≥ 25 304 (37.8) 232 (40.5) 72 (31.2)
Drinking 0.489
    No 553 (68.8) 390 (68.1) 163 (70.6)
    Yes 251 (31.2) 183 (31.9) 68 (29.4)
Smoking 0.983
    No 526 (65.4) 375 (65.4) 151 (65.4)
    Yes 278 (34.6) 198 (34.6) 80 (34.6)
ECOG score 0.029
    0-1 734 (91.3) 531 (92.7) 203 (87.9)
    2 70 (8.7) 42 (7.3) 28 (12.1)
Comorbidity
    Hypertension 218 (27.1) 156 (27.2) 62 (26.8) 0.911
    Pancreatitis 65 (8.1) 52 (9.1) 13 (5.6) 0.105
    Diabetes mellitus 157(19.5) 119 (20.8) 38 (16.5) 0.162
Upper-abdominal operation history 0.717
    No 759 (94.4) 542 (94.6) 217 (93.9)
    Yes 45 (5.6) 31 (5.4) 14 (6.1)
Preoperative biliary drainage 0.009
    No 682 (84.8) 498 (86.9) 184 (79.7)
    Yes 122 (15.2) 75 (13.1) 47 (20.3)
Pathology < 0.001
    Malignant tumor 618 (76.9) 414 (72.3) 204 (88.3)
    Benign tumor 186 (23.1) 159 (27.7) 27 (11.7)
ASA physical status 0.083
    II 514 (63.9) 377 (65.8) 137 (59.3)
    III 290 (36.1) 196 (34.2) 94 (40.7)
ALT, U/L, mean ± SD 134.91 ± 144.16 122.26 ± 134.32 166.31 ± 162.17 < 0.001
    < 40 257 (32.0) 214 (37.3) 43 (18.6) < 0.001
    ≥ 40 547 (68.0) 359 (62.7) 188 (81.4)
AST, U/L, mean ± SD 104.40 ± 134.09 92.11 ± 128.77 134.89 ± 142.22 < 0.001
    < 35 549 (68.3) 349 (60.9) 31 (13.4) < 0.001
    ≥ 35 255 (31.7) 224 (39.1) 200 (86.6)
ALP, U/L, mean ± SD 345.49 ± 305.36 287.75 ± 263.95 488.72 ± 351.25 < 0.001
    < 140 268 (33.3) 239 (41.7) 29 (12.6) < 0.001
    ≥ 140 536 (66.7) 334 (58.3) 202 (87.4)
GGT, U/L, mean ± SD 511.57 ± 559.77 115.90 ± 529.70 667.70 ± 601.57 < 0.001
    < 54 217 (27.0) 195 (34.0) 22 (9.5) < 0.001
    ≥ 54 587 (73.0) 378 (66.0) 209 (90.5)
TBIL, μmol/L, mean ± SD 125.95 ± 141.75 87.95 ± 109.20 220.19 ± 167.27 < 0.001
    < 235.0 547 (68.0) 449 (78.4) 98 (42.4) < 0.001
    ≥ 235.0 257 (32.0) 124 (21.6) 133 (57.6)
Albumin, g/L, mean ± SD 39.55 ± 5.65 40.74 ± 5.28 36.60 ± 5.47 < 0.001
    < 35 152 (18.9) 60 (10.5) 92 (39.8) < 0.001
    ≥ 35 652 (81.1) 513 (89.5) 139 (60.2)
CRP, mg/L, mean ± SD 12.72 ± 21.03 12.14 ± 21.65 14.14 ± 19.39 < 0.001
    < 10 564 (70.1) 425 (74.2) 139 (60.2) < 0.001
    ≥ 10 240 (29.9) 148 (25.8) 92 (39.8)
PT, second, mean ± SD 12.32 ± 1.39 12.26 ± 1.32 12.47 ± 1.54 0.105
    < 14 730 (90.8) 523 (91.3) 207 (89.6) 0.460
    ≥ 14 74 (9.2) 50 (8.7) 24 (10.4)
Hemoglobin, g/L, mean ± SD 126.52 ± 18.88 131.65 ± 16.46 113.80 ± 18.49 < 0.001
    < 115 192 (23.9) 79 (13.8) 113 (48.9) < 0.001
    ≥ 115 612 (76.1) 494 (86.2) 118 (51.1)
Leucocytes, 109/L, mean ± SD 6.37 ± 2.64 6.13 ± 2.43 6.96 ± 3.03 < 0.001
    < 9.5 722 (89.8) 521 (90.9) 201 (87.0)
    ≥ 9.5 82 (10.2) 52 (9.1) 30 (13.0) 0.097
Lymphocyte, 109/L, mean ± SD 1.55 ± 0.60 1.64 ± 0.59 1.33 ± 0.57 < 0.001
    < 3.2 797 (99.1) 567 (99.0) 230 (99.6) 0.680 (F)
    ≥ 3.2 7 (0.9) 6 (1.0) 1 (0.4)
Platelet, 109/L, mean ± SD 258.893 ± 88.76 249.92 ± 75.82 281.27 ± 111.84 < 0.001
    < 350 698 (86.8) 518 (90.4) 180 (77.9) < 0.001
    ≥ 350 106 (13.2) 55 (9.6) 51 (22.1)
NLR, mean ± SD 3.23 ± 2.94 2.70 ± 2.46 4.54 ± 3.56 < 0.001
PLR, mean ± SD 197.51 ± 101.20 187.46 ± 95.80 222.45 ± 109.82 < 0.001
PNI, mean ± SD 46.94 ± 6.766 48.26 ± 6.35 43.69 ± 6.64 < 0.001

ECOG: Eastern Cooperative Oncology Group; ASA: American Society of Anesthesiologists; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase; GGT: γ-glutamyl transferase; TBIL: Total bilirubin; CRP: C-reactive protein; PT: Prothrombin time; NLR: Neutrophil-to-lymphocyte ratio; PLR: Platelet-to-lymphocyte ratio; PNI: Prognostic nutritional index.